Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry

by Gillette, Michael A, Carr, Steven A
Published 2013

Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare

by Gillette, Michael, Taylor, Addison, Butulija, Djenita, Kadiyala, Himabindu, Jneid, Hani
Published in Cardiovasc Drugs Ther (2020)

Simplified and Efficient Quantification of Low-abundance Proteins at Very High Multiplex via Targeted Mass Spectrometry

by Burgess, Michael W., Keshishian, Hasmik, Mani, D. R., Gillette, Michael A., Carr, Steven A.
Published 2014

Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor

by Pickett, June K., Shah, Maulin, Gillette, Michael, Jones, Peter, Virani, Salim, Ballantyne, Christie, Nambi, Vijay
Published in JACC Case Rep (2020)

Accurate Inclusion Mass Screening: A Bridge from Unbiased Discovery to Targeted Assay Development for Biomarker Verification

by Jaffe, Jacob D., Keshishian, Hasmik, Chang, Betty, Addona, Theresa A., Gillette, Michael A., Carr, Steven A.
Published 2008

Metagene projection for cross-platform, cross-species characterization of global transcriptional states

by Tamayo, Pablo, Scanfeld, Daniel, Ebert, Benjamin L., Gillette, Michael A., Roberts, Charles W. M., Mesirov, Jill P.
Published 2007

Leukocytosis in Patients with Neurologic Deterioration after Acute Ischemic Stroke is Associated with Poor Outcomes

by Kumar, Andre D., Boehme, Amelia K., Siegler, James E., Gillette, Michael, Albright, Karen C., Martin-Schild, Sheryl
Published in J Stroke Cerebrovasc Dis (2012)

PEPPeR: A Platform for Experimental Proteomic Pattern Recognition

by Jaffe, Jacob D., Mani, D. R., Leptos, Kyriacos C., Church, George M., Gillette, Michael A., Carr, Steven A.
Published 2009

What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke?

by Siegler, James E., Boehme, Amelia K., Kumar, Andre D., Gillette, Michael A., Albright, Karen C., Martin-Schild, Sheryl
Published in J Stroke Cerebrovasc Dis (2012)

Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry

by Keshishian, Hasmik, Burgess, Michael W, Specht, Harrison, Wallace, Luke, Clauser, Karl R, Gillette, Michael A, Carr, Steven A
Published in Nat Protoc (2017)

Identification of modifiable and non-modifiable risk factors for neurological deterioration following acute ischemic stroke

by Siegler, James E., Boehme, Amelia K., Kumar, Andre D., Gillette, Michael A., Albright, Karen C., Beasley, T. Mark, Martin-Schild, Sheryl
Published 2012

Persistent Leukocytosis—Is this a Persistent Problem for Patients with Acute Ischemic Stroke?

by Boehme, Amelia K., Kumar, Andre D., Lyerly, Michael J., Gillette, Michael A., Siegler, James E., Albright, Karen C., Beasley, T. Mark, Martin-Schild, Sheryl
Published in J Stroke Cerebrovasc Dis (2014)

Time to Neurological Deterioration in Ischemic Stroke

by Siegler, James E., Albright, Karen C., George, Alexander J., Boehme, Amelia K., Gillette, Michael A., Kumar, Andre D., Aswani, Monica, Martin-Schild, Sheryl
Published in Med Student Res J (2017)

A Human Proteome Detection and Quantitation Project

by Anderson, N. Leigh, Anderson, Norman G., Pearson, Terry W., Borchers, Christoph H., Paulovich, Amanda G., Patterson, Scott D., Gillette, Michael, Aebersold, Ruedi, Carr, Steven A.
Published 2009

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

by Subramanian, Aravind, Tamayo, Pablo, Mootha, Vamsi K., Mukherjee, Sayan, Ebert, Benjamin L., Gillette, Michael A., Paulovich, Amanda, Pomeroy, Scott L., Golub, Todd R., Lander, Eric S., Mesirov, Jill P.
Published 2005

Integrated proteomic analysis of post-translational modifications by serial enrichment

by Mertins, Philipp, Qiao, Jana W, Patel, Jinal, Udeshi, Namrata D, Clauser, Karl R, Mani, D R, Burgess, Michael W, Gillette, Michael A, Jaffe, Jacob D, Carr, Steven A
Published 2013

Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury

by Keshishian, Hasmik, Burgess, Michael W., Gillette, Michael A., Mertins, Philipp, Clauser, Karl R., Mani, D. R., Kuhn, Eric W., Farrell, Laurie A., Gerszten, Robert E., Carr, Steven A.
Published in Mol Cell Proteomics (2015)

Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium

by Ellis, Matthew J., Gillette, Michael, Carr, Steven A., Paulovich, Amanda G., Smith, Richard D., Rodland, Karin K., Townsend, R. Reid, Kinsinger, Christopher, Mesri, Mehdi, Rodriguez, Henry, Liebler, Daniel C.
Published 2013

A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease

by Addona, Terri A, Shi, Xu, Keshishian, Hasmik, Mani, D R, Burgess, Michael, Gillette, Michael A, Clauser, Karl R, Shen, Dongxiao, Lewis, Gregory D, Farrell, Laurie A, Fifer, Michael A, Sabatine, Marc S, Gerszten, Robert E, Carr, Steven A
Published 2011

A Curated Resource for Phosphosite-specific Signature Analysis

by Krug, Karsten, Mertins, Philipp, Zhang, Bin, Hornbeck, Peter, Raju, Rajesh, Ahmad, Rushdy, Szucs, Matthew, Mundt, Filip, Forestier, Dominique, Jane-Valbuena, Judit, Keshishian, Hasmik, Gillette, Michael A., Tamayo, Pablo, Mesirov, Jill P., Jaffe, Jacob D., Carr, Steven A., Mani, D. R.
Published in Mol Cell Proteomics (2019)